A Safety/Efficacy Study of a Non-steroid, Topical Cream Treatment of Psoriasis Over 12-weeks
Status:
Completed
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
Psoriasis is a chronic inflammatory skin disorder that is characterized by hyperproliferation
of the keratinocytes and inflammation of the epidermal and dermal layers of the skin. This
study, in patients with mild to moderate plaque psoriasis, is designed to further determine
the efficacy, safety and tolerability of the novel, topically applied, non-steroid,
anti-inflammatory WBI-1001 cream over a period of 12 weeks.